- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Forest Laboratories Inc
+ Add to WatchlistFRX:US
41.8400 USD 0.2700 0.65%As of 20:04:01 ET on 06/19/2013.
Snapshot for Forest Laboratories Inc (FRX)
| Open: | 41.3600 | Day's Range: | 41.3400 - 43.8500 | Volume: | 5,978,717 |
|---|---|---|---|---|---|
| Previous Close: | 41.5700 | 52wk Range: | 31.2800 - 43.8500 | 1-Yr Rtn: | +21.03% |
Key Statistics for FRX
| Current P/E Ratio (ttm) | 246.1176 |
|---|---|
| Estimated P/E(03/2014) | 47.8171 |
| Relative P/E vs. SPX | 15.4238 |
| Earnings Per Share (USD) (ttm) | 0.1700 |
| Est. EPS (USD) (03/2014) | 0.8750 |
| Est. PEG Ratio | 1.3803 |
| Market Cap (M USD) | 11,157.47 |
| Shares Outstanding (M) | 266.67 |
| 30 Day Average Volume | 1,741,711 |
| Price/Book (mrq) | 1.9408 |
| Price/Sale (ttm) | 3.6084 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/17/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FRX
Company Profile & Key Executives for FRX
Forest Laboratories, Inc. develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners.
| Howard SolomonChairman/President/CEO | Elaine HochbergExec VP/Chief Commercial Ofcr |
| Herschel S WeinsteinSenior VP/Secretary/General Counsel | David F SolomonSenior VP:Corporate Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FRX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page